Levodopa ethylester: A novel rescue therapy for response fluctuations in Parkinson's disease

Annals of Neurology

Volumn 39, Issue 3, 1996, Pages 400-404

  Djaldetti, Ruth ^a   Melamed, Eldad ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG SOLUBILITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTERS; ETHANOL; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE; PRODRUGS; TIME FACTORS;

EID: 0030006032     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390321     Document Type: Article

References (20)

1. Marsden CD, Parkes JD, Quinn N. Fluctuations of disability in Parkinson's disease: clinical aspects. In Marsden CD, Fahn S, eds. Movement disorders. London: Buttenvorth, 1982:96-122
2. Poewe WH. Clinical aspects of motor fluctuations in Parkinson's disease. Neurology 1994;44;S6-S9
3. Fabbrini G, Juncos JL, Mouradian MM, et al. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann Neurol 1987;21:370-376
4. Fabbrini G, Mouradian MM, Juncos JL, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part 1. Ann Neurol 1988;24:366-371
5. Melamed E, Bitton V, Zelig O. Delayed onset of response to single doses of L-dopa in parkinsoman fluctuators on long-term L-dopa therapy. Clin Neuropharmacol 1986;9:182-188
6. Melamed E, Bitton V, Zehg O. Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators. Neurology 1986;36:100-103
7. Poewe W. Clinical and pathophysiologic aspects of late levodopa failure. Neurology 1993;43:S28-S30
8. Kurlan R, Rothfield KP, Woodward WR, et al. Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility. Neurology 1988;38:419-421
9. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996 (In press)
10. Deleu D, Ebinger G, Michotte Y. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa. Eur J Clin Pharmacol 1991;41:453-458
11. Kurth MC, Tetrud JW, Tanner CM, et al. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with "on-off" fluctuations. Neurology 1993;43:1698-1703
12. Van Laar T, Jansen EN, Essink AW, et al. A double-blind study of the efficacy of apomorphine and its assessment in "off"-periods in Parkinson's disease. Clin Neurol Neurosurg 1993;96:231-235
13. Frankel JP, Lees AJ, Kempster PA, et al. Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:96-101
14. Ruggieri S, Stocclii F, Carta A, et al. One year treatment with lisuride delivery pump in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:173-183
15. Vaamonde J, Luguin MR, Obeso JA. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease. Mov Disord 1990;6:260-262
16. Steiger MJ, Stocchi F, Bramante L, et al. The clinical efficacy of single morning doses of levodopa methyl ester, dispersible Madopar and Sinemet Plus in Parkinson's disease. Clin Neuropharmacol 1992;15:501-504
17. Stocchi F, Ruggieri S, Carta A, et al. Intravenous boluses and continuous infusions of levodopa methyl ester in fluctuating patients with Parkinson's disease. Mov Disord 1992;7:249-256
18. Stocchi F, Quinn NP, Barbara L, et al. Comparison between a fast and slow preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study. Clin Neuropharmacol 1994;17:38-44
19. Hardie RJ, Malcolm SL, Lees AJ, et al. The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations. Br J Clin Pharmacol 1986;22:429-436
20. Bergman S, Curzon G, Friedel J, et al. The absorption and metabolism of a standard oral dose of levodopa in patients with parkinsonism. Br J Clin Pharmacol 1974;1:417-424